Hematopoietic stem cells with granulo-monocytic differentiation state overcome venetoclax sensitivity in patients with myelodysplastic syndromes
Open Access
- 18 March 2024
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-5
Abstract
The molecular mechanisms of venetoclax-based therapy failure in patients with acute myeloid leukemia were recently clarified, but the mechanisms by which patients with myelodysplastic syndromes (MDS) acquire secondary resistance to venetoclax after an initial response remain to be elucidated. Here, we show an expansion of MDS hematopoietic stem cells (HSCs) with a granulo-monocytic-biased transcriptional differentiation state in MDS patients who initially responded to venetoclax but eventually relapsed. While MDS HSCs in an undifferentiated cellular state are sensitive to venetoclax treatment, differentiation towards a granulo-monocytic-biased transcriptional state, through the acquisition or expansion of clones with STAG2 or RUNX1 mutations, affects HSCs’ survival dependence from BCL2-mediated anti-apoptotic pathways to TNFα-induced pro-survival NF-κB signaling and drives resistance to venetoclax-mediated cytotoxicity. Our findings reveal how hematopoietic stem and progenitor cell (HSPC) can eventually overcome therapy-induced depletion and underscore the importance of using close molecular monitoring to prevent HSPC hierarchical change in MDS patients enrolled in clinical trials of venetoclax.Keywords
This publication has 20 references indexed in Scilit:
- Emerging treatments for myelodysplastic syndromes: Biological rationales and clinical translationCell Reports Medicine, 2023
- Isolation, culture, and immunophenotypic analysis of bone marrow HSPCs from patients with myelodysplastic syndromesSTAR Protocols, 2022
- Azacitidine plus venetoclax in patients with high-risk myelodysplastic syndromes or chronic myelomonocytic leukaemia: phase 1 results of a single-centre, dose-escalation, dose-expansion, phase 1–2 studyThe Lancet Haematology, 2022
- Nicotinamide Metabolism Mediates Resistance to Venetoclax in Relapsed Acute Myeloid Leukemia Stem CellsCell Stem Cell, 2020
- Comprehensive Integration of Single-Cell DataCell, 2019
- Metascape provides a biologist-oriented resource for the analysis of systems-level datasetsNature Communications, 2019
- Integrated Single-Cell Analysis Maps the Continuous Regulatory Landscape of Human Hematopoietic DifferentiationCell, 2018
- Single-cell analysis reveals the continuum of human lympho-myeloid progenitor cellsNature Immunology, 2017
- Human haematopoietic stem cell lineage commitment is a continuous processNature Cell Biology, 2017
- Outcome of patients with myelodysplastic syndrome after failure of decitabine therapyCancer, 2010